AU Patent

AU2005298791B2 — Method of using adapalene in acne maintenance therapy

Assigned to Galderma Research and Development SNC · Expires 2011-04-14 · 15y expired

What this patent protects

Patent listed against Differin.

Drugs covered by this patent

Patent Metadata

Patent number
AU2005298791B2
Jurisdiction
AU
Classification
—
Expires
2011-04-14
Drug substance claim
No
Drug product claim
No
Assignee
Galderma Research and Development SNC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.